Clamidia, gonorrea, tricomoniasis y sífilis

Estimaciones de prevalencia e incidencia mundiales, 2016

Translated title of the contribution: Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016

Jane Rowley, Stephen Vander Hoorn, Eline Korenromp, Nicola Low, Magnus Unemo, Laith Aburaddad, R. Matthew Chico, Alex Smolak, Lori Newman, Sami Gottlieb, Soe Soe Thwin, Nathalie Broutet, Melanie M. Taylor

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective To generate estimates of the global prevalence and incidence of urogenital infection with chlamydia, gonorrhoea, trichomoniasis and syphilis in women and men, aged 15–49 years, in 2016. Methods For chlamydia, gonorrhoea and trichomoniasis, we systematically searched for studies conducted between 2009 and 2016 reporting prevalence. We also consulted regional experts. To generate estimates, we used Bayesian meta-analysis. For syphilis, we aggregated the national estimates generated by using Spectrum-STI. Findings For chlamydia, gonorrhoea and/or trichomoniasis, 130 studies were eligible. For syphilis, the Spectrum-STI database contained 978 data points for the same period. The 2016 global prevalence estimates in women were: chlamydia 3.8% (95% uncertainty interval, UI: 3.3–4.5); gonorrhoea 0.9% (95% UI: 0.7–1.1); trichomoniasis 5.3% (95% UI:4.0–7.2); and syphilis 0.5% (95% UI: 0.4–0.6). In men prevalence estimates were: chlamydia 2.7% (95% UI: 1.9–3.7); gonorrhoea 0.7% (95% UI: 0.5–1.1); trichomoniasis 0.6% (95% UI: 0.4–0.9); and syphilis 0.5% (95% UI: 0.4–0.6). Total estimated incident cases were 376.4 million: 127.2 million (95% UI: 95.1–165.9 million) chlamydia cases; 86.9 million (95% UI: 58.6–123.4 million) gonorrhoea cases; 156.0 million (95% UI: 103.4–231.2 million) trichomoniasis cases; and 6.3 million (95% UI: 5.5–7.1 million) syphilis cases. Conclusion Global estimates of prevalence and incidence of these four curable sexually transmitted infections remain high. The study highlights the need to expand data collection efforts at country level and provides an initial baseline for monitoring progress of the World Health Organization global health sector strategy on sexually transmitted infections 2016–2021.

Original languageSpanish
JournalBulletin of the World Health Organization
Volume97
Issue number8
DOIs
Publication statusPublished - 1 Aug 2019

Fingerprint

Chlamydia
Gonorrhea
Syphilis
Sexually Transmitted Diseases
Incidence
Chlamydia Infections
Bayes Theorem
Uncertainty
Meta-Analysis
Databases

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Clamidia, gonorrea, tricomoniasis y sífilis : Estimaciones de prevalencia e incidencia mundiales, 2016. / Rowley, Jane; Hoorn, Stephen Vander; Korenromp, Eline; Low, Nicola; Unemo, Magnus; Aburaddad, Laith; Chico, R. Matthew; Smolak, Alex; Newman, Lori; Gottlieb, Sami; Thwin, Soe Soe; Broutet, Nathalie; Taylor, Melanie M.

In: Bulletin of the World Health Organization, Vol. 97, No. 8, 01.08.2019.

Research output: Contribution to journalArticle

Rowley, J, Hoorn, SV, Korenromp, E, Low, N, Unemo, M, Aburaddad, L, Chico, RM, Smolak, A, Newman, L, Gottlieb, S, Thwin, SS, Broutet, N & Taylor, MM 2019, 'Clamidia, gonorrea, tricomoniasis y sífilis: Estimaciones de prevalencia e incidencia mundiales, 2016', Bulletin of the World Health Organization, vol. 97, no. 8. https://doi.org/10.2471/BLT.18.228486
Rowley, Jane ; Hoorn, Stephen Vander ; Korenromp, Eline ; Low, Nicola ; Unemo, Magnus ; Aburaddad, Laith ; Chico, R. Matthew ; Smolak, Alex ; Newman, Lori ; Gottlieb, Sami ; Thwin, Soe Soe ; Broutet, Nathalie ; Taylor, Melanie M. / Clamidia, gonorrea, tricomoniasis y sífilis : Estimaciones de prevalencia e incidencia mundiales, 2016. In: Bulletin of the World Health Organization. 2019 ; Vol. 97, No. 8.
@article{ff722fc1859f461f8bc1df769e324f7f,
title = "Clamidia, gonorrea, tricomoniasis y s{\'i}filis: Estimaciones de prevalencia e incidencia mundiales, 2016",
abstract = "Objective To generate estimates of the global prevalence and incidence of urogenital infection with chlamydia, gonorrhoea, trichomoniasis and syphilis in women and men, aged 15–49 years, in 2016. Methods For chlamydia, gonorrhoea and trichomoniasis, we systematically searched for studies conducted between 2009 and 2016 reporting prevalence. We also consulted regional experts. To generate estimates, we used Bayesian meta-analysis. For syphilis, we aggregated the national estimates generated by using Spectrum-STI. Findings For chlamydia, gonorrhoea and/or trichomoniasis, 130 studies were eligible. For syphilis, the Spectrum-STI database contained 978 data points for the same period. The 2016 global prevalence estimates in women were: chlamydia 3.8{\%} (95{\%} uncertainty interval, UI: 3.3–4.5); gonorrhoea 0.9{\%} (95{\%} UI: 0.7–1.1); trichomoniasis 5.3{\%} (95{\%} UI:4.0–7.2); and syphilis 0.5{\%} (95{\%} UI: 0.4–0.6). In men prevalence estimates were: chlamydia 2.7{\%} (95{\%} UI: 1.9–3.7); gonorrhoea 0.7{\%} (95{\%} UI: 0.5–1.1); trichomoniasis 0.6{\%} (95{\%} UI: 0.4–0.9); and syphilis 0.5{\%} (95{\%} UI: 0.4–0.6). Total estimated incident cases were 376.4 million: 127.2 million (95{\%} UI: 95.1–165.9 million) chlamydia cases; 86.9 million (95{\%} UI: 58.6–123.4 million) gonorrhoea cases; 156.0 million (95{\%} UI: 103.4–231.2 million) trichomoniasis cases; and 6.3 million (95{\%} UI: 5.5–7.1 million) syphilis cases. Conclusion Global estimates of prevalence and incidence of these four curable sexually transmitted infections remain high. The study highlights the need to expand data collection efforts at country level and provides an initial baseline for monitoring progress of the World Health Organization global health sector strategy on sexually transmitted infections 2016–2021.",
author = "Jane Rowley and Hoorn, {Stephen Vander} and Eline Korenromp and Nicola Low and Magnus Unemo and Laith Aburaddad and Chico, {R. Matthew} and Alex Smolak and Lori Newman and Sami Gottlieb and Thwin, {Soe Soe} and Nathalie Broutet and Taylor, {Melanie M.}",
year = "2019",
month = "8",
day = "1",
doi = "10.2471/BLT.18.228486",
language = "Spanish",
volume = "97",
journal = "Bulletin of the World Health Organization",
issn = "0042-9686",
publisher = "World Health Organization",
number = "8",

}

TY - JOUR

T1 - Clamidia, gonorrea, tricomoniasis y sífilis

T2 - Estimaciones de prevalencia e incidencia mundiales, 2016

AU - Rowley, Jane

AU - Hoorn, Stephen Vander

AU - Korenromp, Eline

AU - Low, Nicola

AU - Unemo, Magnus

AU - Aburaddad, Laith

AU - Chico, R. Matthew

AU - Smolak, Alex

AU - Newman, Lori

AU - Gottlieb, Sami

AU - Thwin, Soe Soe

AU - Broutet, Nathalie

AU - Taylor, Melanie M.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Objective To generate estimates of the global prevalence and incidence of urogenital infection with chlamydia, gonorrhoea, trichomoniasis and syphilis in women and men, aged 15–49 years, in 2016. Methods For chlamydia, gonorrhoea and trichomoniasis, we systematically searched for studies conducted between 2009 and 2016 reporting prevalence. We also consulted regional experts. To generate estimates, we used Bayesian meta-analysis. For syphilis, we aggregated the national estimates generated by using Spectrum-STI. Findings For chlamydia, gonorrhoea and/or trichomoniasis, 130 studies were eligible. For syphilis, the Spectrum-STI database contained 978 data points for the same period. The 2016 global prevalence estimates in women were: chlamydia 3.8% (95% uncertainty interval, UI: 3.3–4.5); gonorrhoea 0.9% (95% UI: 0.7–1.1); trichomoniasis 5.3% (95% UI:4.0–7.2); and syphilis 0.5% (95% UI: 0.4–0.6). In men prevalence estimates were: chlamydia 2.7% (95% UI: 1.9–3.7); gonorrhoea 0.7% (95% UI: 0.5–1.1); trichomoniasis 0.6% (95% UI: 0.4–0.9); and syphilis 0.5% (95% UI: 0.4–0.6). Total estimated incident cases were 376.4 million: 127.2 million (95% UI: 95.1–165.9 million) chlamydia cases; 86.9 million (95% UI: 58.6–123.4 million) gonorrhoea cases; 156.0 million (95% UI: 103.4–231.2 million) trichomoniasis cases; and 6.3 million (95% UI: 5.5–7.1 million) syphilis cases. Conclusion Global estimates of prevalence and incidence of these four curable sexually transmitted infections remain high. The study highlights the need to expand data collection efforts at country level and provides an initial baseline for monitoring progress of the World Health Organization global health sector strategy on sexually transmitted infections 2016–2021.

AB - Objective To generate estimates of the global prevalence and incidence of urogenital infection with chlamydia, gonorrhoea, trichomoniasis and syphilis in women and men, aged 15–49 years, in 2016. Methods For chlamydia, gonorrhoea and trichomoniasis, we systematically searched for studies conducted between 2009 and 2016 reporting prevalence. We also consulted regional experts. To generate estimates, we used Bayesian meta-analysis. For syphilis, we aggregated the national estimates generated by using Spectrum-STI. Findings For chlamydia, gonorrhoea and/or trichomoniasis, 130 studies were eligible. For syphilis, the Spectrum-STI database contained 978 data points for the same period. The 2016 global prevalence estimates in women were: chlamydia 3.8% (95% uncertainty interval, UI: 3.3–4.5); gonorrhoea 0.9% (95% UI: 0.7–1.1); trichomoniasis 5.3% (95% UI:4.0–7.2); and syphilis 0.5% (95% UI: 0.4–0.6). In men prevalence estimates were: chlamydia 2.7% (95% UI: 1.9–3.7); gonorrhoea 0.7% (95% UI: 0.5–1.1); trichomoniasis 0.6% (95% UI: 0.4–0.9); and syphilis 0.5% (95% UI: 0.4–0.6). Total estimated incident cases were 376.4 million: 127.2 million (95% UI: 95.1–165.9 million) chlamydia cases; 86.9 million (95% UI: 58.6–123.4 million) gonorrhoea cases; 156.0 million (95% UI: 103.4–231.2 million) trichomoniasis cases; and 6.3 million (95% UI: 5.5–7.1 million) syphilis cases. Conclusion Global estimates of prevalence and incidence of these four curable sexually transmitted infections remain high. The study highlights the need to expand data collection efforts at country level and provides an initial baseline for monitoring progress of the World Health Organization global health sector strategy on sexually transmitted infections 2016–2021.

UR - http://www.scopus.com/inward/record.url?scp=85070221092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070221092&partnerID=8YFLogxK

U2 - 10.2471/BLT.18.228486

DO - 10.2471/BLT.18.228486

M3 - Article

VL - 97

JO - Bulletin of the World Health Organization

JF - Bulletin of the World Health Organization

SN - 0042-9686

IS - 8

ER -